Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
December 31, 2025 -120.4%
September 30, 2025 -243.1%
June 30, 2025 -112.2%
March 31, 2025 -29.90%
December 31, 2024 19.42%
September 30, 2024 11.36%
June 30, 2024 -9.58%
March 31, 2024 -9.05%
December 31, 2023 -2.11%
September 30, 2023 33.04%
June 30, 2023 23.57%
March 31, 2023 15.80%
December 31, 2022 -6.65%
September 30, 2022 84.90%
June 30, 2022 87.83%
March 31, 2022 45.70%
December 31, 2021 59.17%
September 30, 2021 87.66%
June 30, 2021 48.11%
March 31, 2021 27.00%
December 31, 2020 43.14%
September 30, 2020 49.46%
June 30, 2020 46.38%
March 31, 2020 20.56%
December 31, 2019 -7.67%
Date Value
September 30, 2019 29.33%
June 30, 2019 -0.44%
March 31, 2019 11.48%
December 31, 2018 3.24%
September 30, 2018 29.14%
June 30, 2018 -13.90%
March 31, 2018 26.11%
December 31, 2017 -0.29%
September 30, 2017 9.38%
June 30, 2017 60.74%
March 31, 2017 12.82%
December 31, 2016 5.14%
September 30, 2016 7.55%
June 30, 2016 5.05%
March 31, 2016 6.00%
December 31, 2015 -35.09%
September 30, 2015 -52.45%
June 30, 2015 -41.67%
March 31, 2015 -3.66%
December 31, 2014 -3.97%
September 30, 2014 -181.0%
June 30, 2014 -51.72%
March 31, 2014 0.86%
December 31, 2013 -357.4%
September 30, 2013 -10.26%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Vitalhub Corp. 68.08%
Rocket Doctor AI, Inc. -219.4%
NetraMark Holdings, Inc. 0.00%
Reliq Health Technologies, Inc. --
Diagnos, Inc. -2.24K%